Trial Profile
Brexpiprazole for the treatment of acute schizophrenia in the Japanese population
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2019
Price :
$35
*
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- 24 Oct 2019 Status changed from recruiting to discontinued.
- 23 Apr 2018 New trial record